Skip to main content
. 2020 May 19;8:e9212. doi: 10.7717/peerj.9212

Table 1. Characteristics, genotypes of EGF rs2237051 and serum EGF levels in GAgP patients and healthy controls.

Risk of GAgP GAgP patients Healthy controls P-value
N 216 138
Age, years 27.29 ± 4.25 27.10 ± 4.23 0.688
Gender 0.859
Female 85 (39.35%) 53 (38.41%)
Male 131 (60.65%) 85 (61.59%)
BMI, Kg/m2 22.10 ± 3.52 21.28 ± 3.06 0.026*
BMI categories 0.002*
<18.5 26 (12.32%) 20 (14.60%)
>=18.5, <24.9 138 (65.40%) 106 (77.37%)
>=24.9 47 (22.27%) 11 (8.03%)
Mean PLI 2.34 ± 0.39 1.40 ± 0.46 <0.001*
Mean PD, mm 4.82 ± 0.98 1.89 ± 0.61 <0.001*
Mean BI 3.55 ± 0.47 1.17 ± 0.37 <0.001*
Mean AL, mm 4.29 ± 1.44 0.01 ± 0.52 <0.001*
Serum EGF, pg/ml 46.77 ± 9.38 33.54 ± 8.62 <0.001*
Alleles of rs2237051 0.005*
A 311 (71.99%) 171 (61.96%)
G 121 (28.01%) 105 (38.04%)
Genotype of rs2237051 0.009*
GG 12 (5.56%) 19 (13.77%)
AG 97 (44.91%) 67 (48.55%)
AA 107 (49.54%) 52 (37.68%)
Genotype of rs2237051 0.029*
AG/GG 109 (50.46%) 86 (62.32%)
AA 107 (49.54%) 52 (37.68%)
Genotype of rs2237051 0.008*
GG 12 (5.56%) 19 (13.77%)
AG/AA 204 (94.44%) 119 (86.23%)

Notes:

*

P < 0.05, statistical significance.

GAgP, generalized aggressive periodontitis; BMI, body mass index; PLI, plaque index; PD, probing depth; BI, bleeding index; AL, attachment loss; EGF, epidermal growth factor.

Results in table: Mean + SD/N (%).